Advertisement
Screener

Intuitive Surgical, Inc. (ISRG) Increase (Decrease) in Other Operating Liabilities

2.8 / 5 stars · 68/120 Roast Me

Intuitive Surgical, Inc. Increase (Decrease) in Other Operating Liabilities

Intuitive Surgical, Inc. (ISRG) reported Increase (Decrease) in Other Operating Liabilities of $36.80 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-21.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-07-21

  • Intuitive Surgical, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $6.10M, a 92.60% decline year-over-year.
  • Intuitive Surgical, Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $30.70M.
  • Intuitive Surgical, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $28.90M, a 68.14% decline year-over-year.
  • Intuitive Surgical, Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was $40.90M, a 58.85% decline year-over-year.
  • Intuitive Surgical, Inc. increase (decrease) in other operating liabilities for fiscal 2025 was $34.10M, a 68.51% decline from fiscal 2024.
  • Intuitive Surgical, Inc. increase (decrease) in other operating liabilities for fiscal 2024 was $108.30M.
  • Intuitive Surgical, Inc. increase (decrease) in other operating liabilities for fiscal 2023 was -$32.90M, a 127.03% decline from fiscal 2022.
  • Intuitive Surgical, Inc. increase (decrease) in other operating liabilities for fiscal 2022 was $121.70M, a 136.77% increase from fiscal 2021.
Period endIncrease (Decrease) in Other Operating Liabilities 3 monthIncrease (Decrease) in Other Operating Liabilities 3 month as first filedIncrease (Decrease) in Other Operating Liabilities 6 monthIncrease (Decrease) in Other Operating Liabilities 6 month as first filedIncrease (Decrease) in Other Operating Liabilities 9 monthIncrease (Decrease) in Other Operating Liabilities 9 month as first filedIncrease (Decrease) in Other Operating Liabilities 12 month
2026-06-30$6.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21
$36.80M
10-Q · filed 2026-07-21
$65.70M
derived: sum of 3 quarters · filed 2026-07-21
$106.60M
derived: sum of 4 quarters · filed 2026-07-21
2026-03-31$30.70M
10-Q · filed 2026-04-22
$59.60M
derived: sum of 2 quarters · filed 2026-04-22
$100.50M
derived: sum of 3 quarters · filed 2026-04-22
$182.90M
derived: sum of 4 quarters · filed 2026-07-21
2025-12-31$28.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03
$69.80M
derived: sum of 2 quarters · filed 2026-02-03
$152.20M
derived: sum of 3 quarters · filed 2026-07-21
$34.10M
10-K · filed 2026-02-03
2025-09-30$40.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22
$123.30M
derived: sum of 2 quarters · filed 2026-07-21
$5.20M
10-Q · filed 2025-10-22
$95.90M
derived: sum of 4 quarters · filed 2026-07-21
2025-06-30$82.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-21
-$35.70M
10-Q · filed 2026-07-21
$55.00M
derived: sum of 3 quarters · filed 2026-07-21
$154.40M
derived: sum of 4 quarters · filed 2026-07-21
2025-03-31-$118.10M
10-Q · filed 2026-04-22
-$27.40M
derived: sum of 2 quarters · filed 2026-04-22
$72.00M
derived: sum of 3 quarters · filed 2026-04-22
$66.00M
derived: sum of 4 quarters · filed 2026-04-22
2024-12-31$90.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03
$190.10M
derived: sum of 2 quarters · filed 2026-02-03
$184.10M
derived: sum of 3 quarters · filed 2026-02-03
$108.30M
10-K · filed 2026-02-03
2024-09-30$99.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-22
$93.40M
derived: sum of 2 quarters · filed 2025-10-22
$17.60M
10-Q · filed 2025-10-22
-$187.40M
derived: sum of 4 quarters · filed 2026-02-03
2024-06-30-$6.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-23
-$81.80M
10-Q · filed 2025-07-23
-$286.80M
derived: sum of 3 quarters · filed 2026-02-03
-$146.50M
derived: sum of 4 quarters · filed 2026-02-03
2024-03-31-$75.80M
10-Q · filed 2025-04-23
-$280.80M
derived: sum of 2 quarters · filed 2026-02-03
-$140.50M
derived: sum of 3 quarters · filed 2026-02-03
-$102.20M
derived: sum of 4 quarters · filed 2026-02-03
2023-12-31-$205.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-03
-$64.70M
derived: sum of 2 quarters · filed 2026-02-03
-$26.40M
derived: sum of 3 quarters · filed 2026-02-03
-$32.90M
10-K · filed 2026-02-03
2023-09-30$140.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-18
$178.60M
derived: sum of 2 quarters · filed 2024-10-18
$172.10M
10-Q · filed 2024-10-18
$232.20M
derived: sum of 4 quarters · filed 2025-01-31
2023-06-30$38.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-19
$31.80M
10-Q · filed 2024-07-19
$91.90M
derived: sum of 3 quarters · filed 2025-01-31
$133.80M
derived: sum of 4 quarters · filed 2025-01-31
2023-03-31-$6.50M
10-Q · filed 2024-04-19
$53.60M
derived: sum of 2 quarters · filed 2025-01-31
$95.50M
derived: sum of 3 quarters · filed 2025-01-31
$94.60M
derived: sum of 4 quarters · filed 2025-01-31
2022-12-31$60.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-31
$102.00M
derived: sum of 2 quarters · filed 2025-01-31
$101.10M
derived: sum of 3 quarters · filed 2025-01-31
$121.70M
10-K · filed 2025-01-31
2022-09-30$41.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-20
$41.00M
derived: sum of 2 quarters · filed 2023-10-20
$61.60M
10-Q · filed 2023-10-20
$78.00M
derived: sum of 4 quarters · filed 2024-01-31
2022-06-30-$900.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-24
$19.70M
10-Q · filed 2023-07-24
$36.10M
derived: sum of 3 quarters · filed 2024-01-31
$88.10M
derived: sum of 4 quarters · filed 2024-01-31
2022-03-31$20.60M
10-Q · filed 2023-04-20
$37.00M
derived: sum of 2 quarters · filed 2024-01-31
$89.00M
derived: sum of 3 quarters · filed 2024-01-31
$103.10M
derived: sum of 4 quarters · filed 2024-01-31
2021-12-31$16.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-01-31
$68.40M
derived: sum of 2 quarters · filed 2024-01-31
$82.50M
derived: sum of 3 quarters · filed 2024-01-31
$51.40M
10-K · filed 2024-01-31
2021-09-30$52.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-21
$66.10M
derived: sum of 2 quarters · filed 2022-10-21
$35.00M
10-Q · filed 2022-10-21
$98.50M
derived: sum of 4 quarters · filed 2023-02-10
2021-06-30$14.10M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-22
-$17.00M
10-Q · filed 2022-07-22
$46.50M
derived: sum of 3 quarters · filed 2023-02-10
$34.40M
derived: sum of 4 quarters · filed 2023-02-10
2021-03-31-$31.10M
10-Q · filed 2022-04-22
$32.40M
derived: sum of 2 quarters · filed 2023-02-10
$20.30M
derived: sum of 3 quarters · filed 2023-02-10
$40.60M
derived: sum of 4 quarters · filed 2023-02-10
2020-12-31$63.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10
$51.40M
derived: sum of 2 quarters · filed 2023-02-10
$71.70M
derived: sum of 3 quarters · filed 2023-02-10
$36.90M
10-K · filed 2023-02-10
2020-09-30-$12.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-20
$8.20M
derived: sum of 2 quarters · filed 2021-10-20
-$26.60M
10-Q · filed 2021-10-20
$24.80M
derived: sum of 4 quarters · filed 2022-02-03
2020-06-30$20.30M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-21
-$14.50M
10-Q · filed 2021-07-21
$36.90M
derived: sum of 3 quarters · filed 2022-02-03
$50.40M
derived: sum of 4 quarters · filed 2022-02-03
2020-03-31-$34.80M
10-Q · filed 2021-04-21
$16.60M
derived: sum of 2 quarters · filed 2022-02-03
$30.10M
derived: sum of 3 quarters · filed 2022-02-03
$31.80M
derived: sum of 4 quarters · filed 2022-02-03
2019-12-31$51.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03
$64.90M
derived: sum of 2 quarters · filed 2022-02-03
$66.60M
derived: sum of 3 quarters · filed 2022-02-03
$11.90M
10-K · filed 2022-02-03
2019-09-30$13.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-19
$15.20M
derived: sum of 2 quarters · filed 2020-10-19
-$39.50M
10-Q · filed 2020-10-19
$6.80M
derived: sum of 4 quarters · filed 2021-02-10
2019-06-30$1.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-23
-$53.00M
10-Q · filed 2020-07-23
-$6.70M
derived: sum of 3 quarters · filed 2021-02-10
$200.00K
derived: sum of 4 quarters · filed 2021-02-10
2019-03-31-$54.70M
10-Q · filed 2020-04-17
-$8.40M
derived: sum of 2 quarters · filed 2021-02-10
-$1.50M
derived: sum of 3 quarters · filed 2021-02-10
$20.10M
derived: sum of 4 quarters · filed 2021-02-10
2018-12-31$46.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10
$53.20M
derived: sum of 2 quarters · filed 2021-02-10
$74.80M
derived: sum of 3 quarters · filed 2021-02-10
$37.10M
10-K · filed 2021-02-10
2018-09-30$6.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-18
$28.50M
derived: sum of 2 quarters · filed 2019-10-18
-$9.20M
10-Q · filed 2019-10-18
$279.30M
derived: sum of 4 quarters · filed 2020-02-07
2018-06-30$21.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-22
-$16.10M
10-Q · filed 2019-07-22
$272.40M
derived: sum of 3 quarters · filed 2020-02-07
$209.40M
derived: sum of 4 quarters · filed 2020-02-07
2018-03-31-$37.70M
10-Q · filed 2019-04-19
$250.80M
derived: sum of 2 quarters · filed 2020-02-07
$187.80M
derived: sum of 3 quarters · filed 2020-02-07
$197.80M
derived: sum of 4 quarters · filed 2020-02-07
2017-12-31$288.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07
$225.50M
derived: sum of 2 quarters · filed 2020-02-07
$235.50M
derived: sum of 3 quarters · filed 2020-02-07
$219.40M
10-K · filed 2020-02-07
2017-09-30-$63.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-22
-$53.00M
derived: sum of 2 quarters · filed 2018-10-22
-$69.10M
10-Q · filed 2018-10-22
-$55.20M
derived: sum of 4 quarters · filed 2019-02-04
2017-06-30$10.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-20
-$6.10M
10-Q · filed 2018-07-20
-$6.20M
10-Q · filed 2017-07-21
$7.80M
derived: sum of 3 quarters · filed 2019-02-04
$33.30M
derived: sum of 4 quarters · filed 2019-02-04
2017-03-31-$16.10M
10-Q · filed 2018-04-18
-$2.20M
derived: sum of 2 quarters · filed 2019-02-04
$23.30M
derived: sum of 3 quarters · filed 2019-02-04
$37.90M
derived: sum of 4 quarters · filed 2019-02-04
2016-12-31$13.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04
$39.40M
derived: sum of 2 quarters · filed 2019-02-04
$54.00M
derived: sum of 3 quarters · filed 2019-02-04
$53.70M
10-K · filed 2019-02-04
2016-09-30$25.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-20
$40.10M
derived: sum of 2 quarters · filed 2017-10-20
$39.80M
10-Q · filed 2017-10-20
2016-06-30$14.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-21
$14.30M
10-Q · filed 2017-07-21
2016-03-31-$300.00K
10-Q · filed 2017-04-19
2015-09-30$2.80M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-19
-$1.00M
derived: sum of 2 quarters · filed 2016-10-19
-$16.70M
10-Q · filed 2016-10-19
2015-06-30-$3.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20
-$19.50M
10-Q · filed 2016-07-20
2015-03-31-$15.70M
10-Q · filed 2016-04-19
2014-09-30$1.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21
$23.20M
derived: sum of 2 quarters · filed 2015-10-21
$79.80M
10-Q · filed 2015-10-21
$97.40M
10-Q · filed 2014-10-23
2014-06-30$21.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-22
$78.30M
10-Q · filed 2015-07-22
$102.10M
10-Q · filed 2014-07-24
2014-03-31$56.60M
10-Q · filed 2015-04-22
$82.30M
10-Q · filed 2014-04-25
2013-09-30-$26.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-23
-$5.60M
derived: sum of 2 quarters · filed 2014-10-23
$9.40M
10-Q · filed 2014-10-23
2013-06-30$20.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24
$35.50M
10-Q · filed 2014-07-24
2013-03-31$15.00M
10-Q · filed 2014-04-25
2012-09-30-$8.70M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-18
$5.50M
derived: sum of 2 quarters · filed 2013-10-18
$6.20M
10-Q · filed 2013-10-18
2012-06-30$14.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-22
$14.90M
10-Q · filed 2013-07-22
2012-03-31$700.00K
10-Q · filed 2013-04-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
Edwards Lifesciences Corp (EW)United States$49.409B51.96
STERIS plc (STE)Ireland$20.343B25.49
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81